PointState Capital’s Correvio Pharma CORV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-606,060
Closed -$2.48M – 141
2016
Q1
$2.48M Buy
606,060
+6,060
+1% +$32.4K 0.07% 74
2015
Q4
$4.87M Hold
600,000
– – 0.12% 66
2015
Q3
$5.06M Buy
600,000
+287,563
+92% +$2.65M 0.14% 62
2015
Q2
$2.94M Hold
312,437
– – 0.03% 119
2015
Q1
$2.89M Buy
312,437
+62,437
+25% +$598K 0.04% 101
2014
Q4
$2.31M Buy
+250,000
New +$2.1M 0.04% 99

Other funds holding CORV

PointState Capital's CORV Position: Q2 2016 in Review

PointState Capital sold out of Correvio Pharma (CORV) in Q2 2016, closing a stake of 606,060 shares — an estimated $2.48M sold.

PointState Capital first reported a position in CORV in Q4 2014 and held it in 6 quarters. The position peaked at $5.06M in Q3 2015. 30 funds tracked by Wall St. Rank hold CORV as of Q2 2016.

  • PointState Capital reported no remaining Correvio Pharma position as of Q2 2016 after selling out during the quarter.
  • PointState Capital sold 606,060 Correvio Pharma shares in Q2 2016, an estimated $2.48M.
  • PointState Capital first reported a position in Correvio Pharma in Q4 2014 and held it in 6 quarters.
  • PointState Capital's Correvio Pharma position peaked at $5.06M in Q3 2015.
  • 30 funds tracked by Wall St. Rank held Correvio Pharma as of Q2 2016.

Based on PointState Capital's 13F filing for Q2 2016, filed 15 Aug 2016.